CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a non-invasive prenatal diagnosis method for a wide range of genetic disorders using fetal DNA found in maternal blood. The goal is to create a fast, accurate, and safe diagnostic tool for expectant mothers, expanding beyond current capabilities for trisomy 21.
Non-Invasive Prenatal Diagnosis (NIPD) has been one of the most fascinating research fields during the last decade.
The identification of small amounts of fetal DNA in maternal circulation has opened new possibilities for NIPD.
Up until today, two methods have achieved accurate and validated NIPD methods for trisomy 21.
The first NIPD for trisomy 21 was based on next generation sequencing and the second was developed by our group and is based on a MeDIP real time qPCR.
However, nothing has been…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH CYRUS INSTIT OF NEURO & GENETICS
Cyprus, AGIOS DOMETIOS
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
